Melanie S. Hulshoff

590 total citations
15 papers, 369 citations indexed

About

Melanie S. Hulshoff is a scholar working on Genetics, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Melanie S. Hulshoff has authored 15 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Molecular Biology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Melanie S. Hulshoff's work include Inflammatory Bowel Disease (6 papers), Cancer-related molecular mechanisms research (3 papers) and Microscopic Colitis (2 papers). Melanie S. Hulshoff is often cited by papers focused on Inflammatory Bowel Disease (6 papers), Cancer-related molecular mechanisms research (3 papers) and Microscopic Colitis (2 papers). Melanie S. Hulshoff collaborates with scholars based in Netherlands, Germany and United States. Melanie S. Hulshoff's co-authors include Elisabeth M. Zeisberg, Xingbo Xu, Guido Krenning, Michael Zeisberg, Xiao-Ying Tan, Gonzalo del Monte‐Nieto, Jason C. Kovacic, Björn Tampe, Tobias Moser and Raghu Kalluri and has published in prestigious journals such as Nature Communications, Gastroenterology and International Journal of Molecular Sciences.

In The Last Decade

Melanie S. Hulshoff

14 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Melanie S. Hulshoff Netherlands	8	233	75	68	55	49	15	369
Jianglei Chen United States	10	157 0.7×	57 0.8×	45 0.7×	48 0.9×	41 0.8×	15	359
Patricia Q. Rodriguez Sweden	9	189 0.8×	57 0.8×	60 0.9×	32 0.6×	40 0.8×	20	357
Sofia Annis United States	9	261 1.1×	30 0.4×	160 2.4×	40 0.7×	84 1.7×	17	397
Stephanie Lapping United States	6	183 0.8×	46 0.6×	60 0.9×	23 0.4×	24 0.5×	10	311
Oraly Sanchez-Ferras Canada	6	242 1.0×	20 0.3×	39 0.6×	56 1.0×	52 1.1×	6	365
Nicolle Ceneri United States	6	113 0.5×	30 0.4×	41 0.6×	38 0.7×	47 1.0×	12	282
Akashi Taguchi Japan	7	254 1.1×	28 0.4×	126 1.9×	23 0.4×	29 0.6×	11	406
Lasse Bach Steffensen Denmark	11	100 0.4×	47 0.6×	45 0.7×	33 0.6×	60 1.2×	25	271
М. С. Назаренко Russia	11	215 0.9×	66 0.9×	91 1.3×	56 1.0×	57 1.2×	88	381
Shuyu Wang China	9	152 0.7×	48 0.6×	64 0.9×	9 0.2×	35 0.7×	13	323

Countries citing papers authored by Melanie S. Hulshoff

Since Specialization

Citations

This map shows the geographic impact of Melanie S. Hulshoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie S. Hulshoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie S. Hulshoff more than expected).

Fields of papers citing papers by Melanie S. Hulshoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melanie S. Hulshoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie S. Hulshoff. The network helps show where Melanie S. Hulshoff may publish in the future.

Co-authorship network of co-authors of Melanie S. Hulshoff

This figure shows the co-authorship network connecting the top 25 collaborators of Melanie S. Hulshoff. A scholar is included among the top collaborators of Melanie S. Hulshoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melanie S. Hulshoff. Melanie S. Hulshoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Joustra, V, Andrew Y. F. Li Yim, Peter Henneman, et al.. (2025). Development and validation of peripheral blood DNA methylation signatures to predict response to biological therapy in adults with Crohn's disease (EPIC-CD): an epigenome-wide association study. The Lancet. Gastroenterology & hepatology. 10(9). 818–830. 1 indexed citations

D’Haens, Geert, Mark Löwenberg, Filip Baert, et al.. (2025). Vedolizumab in early and late Crohn's disease (LOVE-CD): a phase 4 open-label cohort study. The Lancet. Gastroenterology & hepatology. 11(1). 12–21.

Rath, Sandip Kumar, Björn Tampe, David S. Yu, et al.. (2024). Loss of tet methyl cytosine dioxygenase 3 (TET3) enhances cardiac fibrosis via modulating the DNA damage repair response. Clinical Epigenetics. 16(1). 119–119. 4 indexed citations

Löwenberg, Mark, Marjolijn Duijvestein, Adriaan A. van Bodegraven, et al.. (2024). Cost‐effectiveness and cost‐utility of optimized mercaptopurine treatment versus placebo in ulcerative colitis patients: The randomized controlled OPTIC trial. United European Gastroenterology Journal. 12(9). 1256–1265. 1 indexed citations

D’Haens, Geert, Carlos Taxonera, Antonio López–Sanromán, et al.. (2024). Vedolizumab to prevent postoperative recurrence of Crohn's disease (REPREVIO): a multicentre, double-blind, randomised, placebo-controlled trial. The Lancet. Gastroenterology & hepatology. 10(1). 26–33. 11 indexed citations

D’Haens, Geert, Carlos Taxonera, Antonio López–Sanromán, et al.. (2023). 603 VEDOLIZUMAB PREVENTS POSTOPERATIVE REUCURRENCE IN CROHN'S DISEASE: RESULTS OF THE REPREVIO TRIAL. Gastroenterology. 164(6). S–111. 1 indexed citations

Hulshoff, Melanie S., Isabel N. Schellinger, Xingbo Xu, et al.. (2023). miR-132-3p and KLF7 as novel regulators of aortic stiffening-associated EndMT in type 2 diabetes mellitus. Diabetology & Metabolic Syndrome. 15(1). 11–11. 12 indexed citations

Hulshoff, Melanie S., et al.. (2023). Efficacious dosing regimens for anti-TNF therapies in inflammatory bowel disease: where do we stand?. Expert Opinion on Biological Therapy. 23(4). 341–351. 3 indexed citations

Xu, Xingbo, Xiao-Ying Tan, Melanie S. Hulshoff, et al.. (2020). Serelaxin alleviates cardiac fibrosis through inhibiting endothelial-to-mesenchymal transition via RXFP1. Theranostics. 10(9). 3905–3924. 44 indexed citations

10.

Xu, Xingbo, Melanie S. Hulshoff, Xiao-Ying Tan, Michael Zeisberg, & Elisabeth M. Zeisberg. (2020). CRISPR/Cas Derivatives as Novel Gene Modulating Tools: Possibilities and In Vivo Applications. International Journal of Molecular Sciences. 21(9). 3038–3038. 32 indexed citations

11.

Hulshoff, Melanie S., Gonzalo del Monte‐Nieto, Jason C. Kovacic, & Guido Krenning. (2019). Non-coding RNA in endothelial-to-mesenchymal transition. Cardiovascular Research. 115(12). 1716–1731. 65 indexed citations

12.

Hulshoff, Melanie S., Xingbo Xu, Guido Krenning, & Elisabeth M. Zeisberg. (2018). Epigenetic Regulation of Endothelial-to-Mesenchymal Transition in Chronic Heart Disease. Arteriosclerosis Thrombosis and Vascular Biology. 38(9). 1986–1996. 74 indexed citations

13.

Xu, Xingbo, Xiao-Ying Tan, Björn Tampe, et al.. (2018). High-fidelity CRISPR/Cas9- based gene-specific hydroxymethylation rescues gene expression and attenuates renal fibrosis. Nature Communications. 9(1). 3509–3509. 107 indexed citations

14.

Hulshoff, Melanie S., Sandip Kumar Rath, Xingbo Xu, Michael Zeisberg, & Elisabeth M. Zeisberg. (2018). Causal Connections From Chronic Kidney Disease to Cardiac Fibrosis. Seminars in Nephrology. 38(6). 629–636. 13 indexed citations

15.

Xu, Xingbo, et al.. (2017). 5042The role of long non coding RNA in gene-specific promoter methylation during cardiac fibrogenesis. European Heart Journal. 38(suppl_1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact